Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 26

    Strides Pharma found destroying, dumping drug production documents: USFDA Investigation

    Strides Pharma found destroying, dumping drug production documents: USFDA Investigation

    Medical Dialogues Bureau20 July 2019 2:16 PM IST
    In the letter to Strides Pharma, the FDA didn't explain whether its inspectors often check scrap yards or shredding rooms for documents, or whether it...
    HC pulls up Pharma co for violating court orders, directs it to plant 33,000 more saplings

    HC pulls up Pharma co for violating court orders, directs it to plant 33,000 more saplings

    Medical Dialogues Bureau19 July 2019 4:55 PM IST
    New Delhi: The Delhi High Court Wednesday termed as "a racket" the submission of a private company, directed to plant 1.4 lakh saplings worth Rs 80...
    DOP rejects Mylan review application for revising retail price of Hepatitis B, HIV drug

    DOP rejects Mylan review application for revising retail price of Hepatitis B, HIV drug

    Farhat Nasim18 July 2019 3:58 PM IST
    New Delhi: Through a recent decision, the Department of Pharmaceuticals has rejected the review application filed by Mylan Pharmaceuticals Private...
    Methodology to Fix Prices of Essential Medicines- Minister informs Parliament

    Methodology to Fix Prices of Essential Medicines- Minister informs Parliament

    Farhat Nasim17 July 2019 4:07 PM IST
    New Delhi: Through a recent reply, the Minister in the Ministry of Chemical and Fertilizers informed the Parliament about the details of the...
    Cipla, Jiangsu Acebright join hands to invest USD 30 million for respiratory products in China

    Cipla, Jiangsu Acebright join hands to invest USD 30 million for respiratory products in China

    Farhat Nasim16 July 2019 1:53 PM IST
    While Cipla EU will hold 80 per cent stake in the joint venture, the rest 20 per cent will be with Acebright, the statement by Cipla said. Mumbai:...
    Cancer Drug Patent Issues: Delhi HC junks Bayer plea to block Natco Pharma Regonat

    Cancer Drug Patent Issues: Delhi HC junks Bayer plea to block Natco Pharma Regonat

    Farhat Nasim15 July 2019 2:52 PM IST
    New Delhi: The Delhi High Court recently junked the injunction petition filed by the German Drugmaker to restrain the Hyderabad-based Natco Pharma...
    Rejected: JnJ plea to waiver Phase IV trial for FDC drug containing Canagliflozin, Metformin

    Rejected: JnJ plea to waiver Phase IV trial for FDC drug containing Canagliflozin, Metformin

    Farhat Nasim14 July 2019 11:30 AM IST
    New Delhi: American multinational drug maker Johnson and Johnson's (JnJ) proposal for waiver of Phase IV clinical trial of its Fixed-Dose Combination...
    Now criminal probe against JnJ for denying presence of carcinogens in Baby Powder: Report

    Now criminal probe against JnJ for denying presence of carcinogens in Baby Powder: Report

    Medical Dialogues Bureau13 July 2019 1:15 PM IST
    The criminal probe, which hasn’t been reported previously, coincides with a regulatory investigation and civil claims by thousands of cancer patients...
    NPPA regulatory measures primarily triggered tough days for hospital sector, says Icra

    NPPA regulatory measures primarily triggered tough days for hospital sector, says Icra

    Medical Dialogues Bureau12 July 2019 6:23 PM IST
    The tough days were triggered primarily on account of several regulatory measures, including the cap on prices of stents and knee implants by the...
    CDSCO Committee turns down Novartis FDC drug including Vildagliptin, Metformin, Glimepiride

    CDSCO Committee turns down Novartis FDC drug including Vildagliptin, Metformin, Glimepiride

    Farhat Nasim11 July 2019 5:38 PM IST
    New Delhi: The Swiss drugmaker, Novartis recently presented before the Central Drugs Standard Control Organization(CDSCO) Technical Committee to seek...
    Fortis ​Healthcare divests 28 percent stake in Mauritius-based Medical and Surgical Centre

    Fortis ​Healthcare divests 28 percent stake in Mauritius-based Medical and Surgical Centre

    Farhat Nasim10 July 2019 11:12 AM IST
    Fortis has 28.89 per cent stake in MSCL while its Mauritius-based partner CIEL Healthcare holds 58.6 per cent. The rest is held by other shareholders....
    Difference of 50-90 percent in prices of Branded and Generic medicines- Minister informs Parliament

    Difference of 50-90 percent in prices of Branded and Generic medicines- Minister informs Parliament

    Farhat Nasim9 July 2019 4:13 PM IST
    New Delhi: Through a recent reply, the Minister in the Ministry of Chemical and Fertilizers has informed the Parliament about the difference between...
    PrevNext

    Popular Stories

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by...

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok